NCT01330303View on ClinicalTrials.gov

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 8, 2009

Primary Completion Date

December 22, 2009

Study Completion Date

December 22, 2009

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Reference formulation

SECOTEX® (tamsulosin hydrochloride) 0,4 mg (Boehringer Ingelheim)

DRUG

Test formulation

tamsulosin hydrochloride 0,4 mg (Synthon BV)

Trial Locations (1)

Unknown

GSK Investigational Site, Campinas

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01330303 - SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin | Biotech Hunter | Biotech Hunter